James Green
Translating the complexity of a world in motion into the intelligence you need.
About This Column
James Green is a writer and strategist dedicated to finding the "signal in the noise" of modern progress. Building on a career spent deconstructing the high-stakes world of biotech and medical innovation, James now applies his forensic curiosity to the broader forces of change. He specializes in translating complex technological, market, and social shifts into clear, actionable insights. Whether he is analyzing a disruptive new industry, a shift in global investment, or the future of infrastructure, James provides the critical context needed to understand how today’s breakthroughs will reshape our world tomorrow.
Displaying items 321-340 of 525 in total
Oryzon's Vafidemstat Gains Key Japan Patent for CNS Disorders
Hankook Tire's Goal: Driving Mideast Dominance with Al Ain FC Deal
Armor Health's Ohio Expansion Met with Praise and Scrutiny
VivoPower's AI Bet: A Green Firm's High-Stakes Pivot to Data Centers
Scilex Bets $20M on AI Diagnostics in Pivot Beyond Pain Management
Northern Jet Soars on Client Trust, Reports Record 2025 Growth
Malaysia Fences for Tourists with Strategic Partnership for VM2026
LeveL Markets and 21X Forge Regulated Path to Tokenized Assets
PublicSquare's Fintech Pivot: New CEO to Steer 'Values-Aligned' Payments
Spirits & Stitches: India's New Luxury Playbook
ABN AMRO Taps Lap for Chair, Nominee Mustier Signals Global Ambition
Jotform and Canva Launch First Native AI Chatbot for Designs
JM&A Group's Gyde Targets F&I Pain Points with Adaptive Technology
JamLoop Taps Brian Bell to Lead Sales as CTV Ad Market Hits Tipping Point
New Era for Glaucoma Care? Adjustable Implant Begins US Trials
Visa Bets on Athlete Journeys Over Podiums for Milano Cortina 2026
Canada's Productivity Crisis: A Polytechnic Blueprint for a Fix
Terra Innovatum Pitches Micro-Nuclear Future on Global Tour
Basel Medical Group on Nasdaq Delisting Watch After Stock Plunge
